NEW YORK, April 11, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

Kristen Scholer delivers the pre-market update on April 11th

• Stocks rose Friday as JP Morgan Chase (NYSE: JPM) exceeded earnings expectations.
• China raised tariffs on U.S. imports to 125% after the White House upped its tariffs to 145% on Chinese imports.
• Traders gave equities a boost after the European Union said its representatives will fly to Washington D.C. to “try and sign deals”

Opening Bell
Project H.O.O.D highlights its efforts to build a Leadership & Economic Opportunity Center on the South Side of Chicago

Closing Bell
YPF S.A. (NYSE: YPF) celebrates and introduces its new management team

Download the NYSE TV App and Subscribe Here 

Video – https://mma.prnasia.com/media2/2662834/NYSE_Market_Update_April_11_2025.mp4

PALO ALTO, Calif., April 11, 2025 /PRNewswire/ — Hesai Group (Nasdaq: HSAI), the global leader in lidar technology for automotive mobility and robotics application, has been named the top automotive lidar company by market share for the fourth consecutive year by Yole Group, a global advisory and market analysis firm recognized for its expertise in the semiconductor, photonic, and electronic sectors. The report highlights Hesai’s continued leadership in the global lidar industry, emphasizing its market-leading revenue share, and dominant presence across both ADAS-enabled passenger cars and the robotaxi segment. This leadership position was bolstered by strategic partnerships with leading global OEMs, ongoing technological innovations, and rapidly growing demand in both the passenger car segment and robotaxi market.

Yole Group’s “Lidar for Automotive 2025” report, which ranks lidar companies by several key indicators of success, noted that Hesai captured 33% of the global market by revenue in 2024. The market has witnessed enormous growth of 60% year-on-year to reach a value of $859 million.

Hesai’s leadership is particularly evident in the rapidly expanding ADAS-enabled passenger vehicle market, which is experiencing explosive growth, particularly in China. Yole Group reports that around 120 vehicle models have adopted lidar since 2018, with adoption accelerating. Nearly 40 new lidar-equipped models have launched in the last two years alone. As the technology continues to grow in popularity, Chinese automakers are now implementing lidar beyond luxury vehicles, into more affordable, mass-market models, including C-segment cars priced around $25,000. This democratization drove the ADAS passenger car lidar market to grow by 68% year-on-year in 2024. This marks a major turning point for the industry as it enters a true mass adoption phase.

Hesai’s scalability, vertical integration, and strategic design wins with 22 OEMs across over 120 models have made it a top supplier in this segment. According to the report, industry leaders, including BYD and Li Auto, are driving this momentum. BYD’s “God’s Eye” intelligent driving system is now available in mass-market models, and Li Auto plans to standardize lidar across its entire 2025 lineup.

In the robotaxi market specifically, Hesai dominates with a commanding 61% market share, supplying industry leaders such as Zoox, Aurora, Apollo, Didi, Pony, and WeRide.

Looking toward 2025, Yole Group expects the adoption of lidar-based ADAS systems, particularly driven by recent commitments from Chinese players, will push lidar installations beyond three million units. Hesai’s growth in tandem with the industry will enable it to remain a leader in the market.

“We are proud to be recognized by Yole Group as the leader in the global lidar market for the fourth year in a row,” said David Li, CEO & Co-Founder of Hesai. “Lidar is experiencing transformative growth as automakers increasingly rely on the technology to drastically increase safety and reliability across both manned and autonomous vehicles. Our advantage lies in the speed and scale at which we innovate and manufacture, driven by our initiative of delivering ultimate performance and ultimate value-to-cost.”

“Hesai’s continued market leadership reflects their sound business model and innovation capabilities across the sector,” said Pierrick Boulay, Senior Analyst at Yole Group. “The Company is uniquely positioned to capitalize on new opportunities as the industry continues to grow.”

 Hesai continues to report the strongest revenue amongst its competitors and is the only company in the industry to have achieved full-year non-GAAP1 profitability. To date, Hesai has secured design wins with 22 automotive OEMs for over 120 vehicle models globally. In December 2024, Hesai became the first lidar company in the world to deliver more than 100,000 units in a single month.

Note: The data in this article represents third party estimates and are not official operational figures of the company. Please refer to the company’s financial report for specific information.

About Hesai

Hesai Group (Nasdaq: HSAI) is a global leader in LIDAR solutions. The company’s LIDAR products enable a broad spectrum of applications including passenger and commercial vehicles (“ADAS”), as well as autonomous driving vehicles and robotics and other non-automotive applications such as last-mile delivery robots and AGVs (“Robotics”). Hesai seamlessly integrates its in-house manufacturing process with LIDAR R&D and design, enabling rapid product iteration while ensuring high performance, high quality and affordability. The company’s commercially validated solutions are backed by superior R&D capabilities across optics, mechanics, and electronics. Hesai has established offices in Shanghai, Palo Alto and Stuttgart, with customers spanning more than 40 countries.

About Yole Group

Yole Group offers a comprehensive range of reports, covering market trends, technology insights, teardowns, and reverse costing analyses. For tailored strategic, technical, or market analysis, as well as answers to specific questions, Yole Group also provides custom consulting services.

More information on yolegroup.com – LinkedIn.

SINGAPORE, April 11, 2025 /PRNewswire/ — Duke-NUS Medical School has appointed Professor Patrick Tan as its next and fourth Dean, effective 1 January 2026, marking a new chapter for the School as it builds on its legacy of medical education, research and innovation. Prof Tan will serve as Dean-designate from 1 July 2025, succeeding Professor Thomas Coffman, the School’s longest-serving Dean since 2015. This leadership transition coincides with the School’s 20^th anniversary, underscoring Duke-NUS’ commitment to advancing the future of healthcare in Singapore and the region.

An internationally recognised cancer geneticist and clinician-scientist, Prof Tan is currently Senior Vice-Dean for Research at Duke-NUS, where he leads transformative research initiatives in genomics, precision medicine and biomedical innovation. He was one of the School’s pioneer faculty members and has been involved in advancing its research strategy.

Prof Tan has also been an active contributor in Singapore’s research landscape, taking on roles including Executive Director of Precision Health Research Singapore (PRECISE), Senior Scientific Advisor at SingHealth and former Executive Director of the Genome Institute of Singapore. His leadership in integrating cutting-edge science with clinical applications has placed him at the forefront of Singapore’s biomedical ecosystem.

A firm believer in team science, Prof Tan is passionate about fostering interdisciplinary collaborations to solve Singapore’s most pressing healthcare challenges. His ability to drive impactful change was recognised with the Exemplary Leader Award at the 2023 Public Sector Transformation Award Ceremony. Other awards include the President’s Science Award (Team), American Association for Cancer Research (AACR) Team Science Award, and election to the American Society of Clinical Investigation and Association of American Physicians.

A strong endorsement from Duke and NUS leadership

Professor Tan Eng Chye, President of the National University of Singapore (NUS), said:
“After a rigorous search within the University and globally, Patrick has been identified as the best candidate to lead Duke-NUS into its next chapter of growth as a key pillar in Singapore’s healthcare and biomedical ecosystem. Patrick brings remarkable visionary leadership and profound expertise through years of dedicated service and contributions as researcher, scientist and educator. I am confident that his leadership and wealth of knowledge will bring the School towards higher levels of excellence, ensuring that our next generation of doctors, researchers and healthcare leaders are well-prepared to meet the challenges of tomorrow.”

Mr Goh Yew Lin, Chairman of the Duke-NUS Governing Board, said:
“Patrick is first and foremost a world-class researcher, but what sets him apart is his deep understanding of how discovery and education must go hand in hand. As a graduate-entry medical school, Duke-NUS trains future clinicians who are not only skilled in patient care but also capable of asking bold questions and driving innovation. As Dean, he will ensure that the School’s research priorities remain aligned with our national Research, Innovation and Enterprise (RIE) strategy, while strengthening translation and partnerships that attract industry collaborators and nurture a culture of innovation among our students.”

Professor Mary Klotman, MD, Executive Vice President for Health Affairs at Duke University, Dean of Duke University School of Medicine, and Chief Academic Officer of Duke Health, welcomed Prof Tan’s appointment:
“We are excited to work with Patrick as he takes on the mantle of the next Dean of Duke-NUS. A distinguished scientist and strategic leader, he brings a clear vision for how cutting-edge research and meaningful education can converge to improve lives. His commitment to collaboration and academic excellence makes him well-positioned to lead Duke-NUS into its next phase—strengthening our global partnership and expanding the School’s contributions to advance health for all.”

The joint search committee to identify the successor for the role of Dean was chaired by Professor Aaron Thean, Deputy President (Academic Affairs) and Provost of the National University of Singapore, as well as Deputy Chairman of Duke-NUS Governing Board; and included faculty members from Duke-NUS, NUS, Duke University, SingHealth and the Duke-NUS Governing Board.

Professor Tan’s Vision for Duke-NUS

Reflecting on his appointment, Professor Patrick Tan shared:
“The healthcare landscape is evolving rapidly, driven by shifting demographics, intensifying demands on healthcare, and technological innovations. These are major challenges, but they also create huge opportunities. As Dean, I look forward to enhancing our long-standing Academic Medicine partnership with SingHealth and harnessing the collective strengths of Duke University and NUS, our parent institutions, to deepen our understanding of diseases and advancing medical solutions that will make a real difference to patients.

“By combining the power of cutting-edge research, medical education and translational innovation, Duke-NUS is uniquely positioned to shape the future of medicine. Together with our valued partners, I am immensely grateful for the opportunity to work with our faculty, students, alumni and stakeholders to build on this strong foundation and drive the School’s next stage of development in Singapore and the world.”

Honouring a Decade of Leadership: Professor Thomas Coffman

Duke-NUS also expresses deep gratitude to Professor Thomas Coffman for his exceptional leadership over the past decade.

A renowned physician-scientist in nephrology and cardiovascular research, Prof Coffman strengthened Duke-NUS’ education and research landscape, ensuring that its training programmes remain rigorous and responsive to Singapore’s evolving healthcare needs. He founded and built up the School’s Cardiovascular and Metabolic Disorders Signature Research Programme as Director. Under his leadership, Duke-NUS also secured strategic funding to advance key research initiatives and played a critical role in Singapore’s COVID-19 response, contributing to innovations such as rapid immune response testing.

Prof Klotman expressed her appreciation for outgoing Dean, Prof Coffman, adding:
“Tom has been an extraordinary bridge between Duke and Duke-NUS, deepening the ties between our institutions and reinforcing the values we share—academic excellence, collaboration and impact. Under his steady and visionary leadership, Duke-NUS has flourished as a beacon of innovation in education, research and clinical care. His legacy is not only reflected in the School’s achievements but in the strength of our transcontinental partnership and global contributions to biomedical science.”

Mr Goh also expressed appreciation to outgoing Dean, Prof Coffman, saying:
“Tom has led Duke-NUS through a defining decade with wisdom, vigour and steady resolve. He has not only guided the School’s academic and research growth, but also shaped a culture that prizes excellence, collaboration and innovation. We are deeply grateful for his contributions and leadership, which have laid a strong foundation for the next chapter.”

Even as he steps down from his role as Dean, Prof Coffman will continue to lead key research initiatives, including DYNAMO, a multi-institutional study focussed on reducing the prevalence of diabetic kidney disease in Singapore and around the world.

###

About Duke-NUS Medical School
Duke-NUS is Singapore’s flagship graduate-entry medical school, established in 2005 with a strategic, government-led partnership between two world-class institutions: Duke University School of Medicine and the National University of Singapore (NUS). Through an innovative curriculum, students at Duke-NUS are nurtured to become multi-faceted ‘Clinicians Plus’ poised to steer the healthcare and biomedical ecosystem in Singapore and beyond. A leader in ground-breaking research and translational innovation, Duke-NUS has gained international renown through its five Signature Research Programmes and ten Centres. The enduring impact of its discoveries is amplified by its successful Academic Medicine partnership with Singapore Health Services (SingHealth), Singapore’s largest healthcare group. This strategic alliance has led to the creation of 15 Academic Clinical Programmes, which harness multi-disciplinary research and education to transform medicine and improve lives.   

For more information, please visit www.duke-nus.edu.sg 

NEW YORK, April 11, 2025 /PRNewswire/ — Double Stitch by Bedsure announced in March that the Organic Cotton Duvet Cover Set was named a winner in Good Housekeeping’s 2025 Bedding Awards. The full list of awards can be found HERE.

The Organic Cotton Duvet Cover won the title of “Stylish and Breathable” within the Duvet Covers category. The title was awarded based on several attributions including quality, innovation, convenience, value, style and sustainability. Crafted from premium 100% long-staple organic cotton, this GOTS-certified cover set undergoes specialized washing for ultimate purity and softness, and features elegant recycled shell buttons adding an environmentally responsible touch without compromising elegance or functionality.

“Forming no pills in our abrasion tests, this durable fabric also held up beautifully to multiple laundry cycles,” Good Housekeeping stated. A Good Housekeeping tester noted that when sleeping with the Organic Duvet Cover Set “I think I’ve been sleeping better than ever under the extra, comforting weight it gives the duvet.” Another tester reported, “I can’t stress enough how soft the organic cotton felt without any strange smells.”

Each year, product experts in the Good Housekeeping Institute spend months testing hundreds of bedding items to help shoppers find the sleep gear worth buying. In addition to evaluating factors like durability, washability and performance using specialized equipment in the GH Institute Textiles Lab, they utilized over 600 sleep testers to try out the bedding in their homes and rate aspects such as comfort, support and ease of use. To choose the winners, judges focused on attributes like quality, innovation, convenience, value, style and sustainability.

Originated from a handcrafted textile factory, Double Stitch is crafted for quality living with premium bedding at accessible prices. Designed for young professionals and families, Double Stitch’s line of creative bedding essentials was designed for those who have a distinct taste and are committed to maintaining a high-quality lifestyle by investing in affordable, stylish, and high-quality products.

The Organic Cotton Duvet Cover Set retails for $149.99 (queen and king) and comes in seven different color options including Desert Sage, Sepia Rose, Pure White, Winter Sky, Coconut Milk, Lilac Bloom and Oat. To learn more about Double Stitch by Bedsure’s Organic Duvet Cover Set, please visit the Double Stitch website and Amazon site.  

Established in 2023, Double Stitch is a premium bedding brand under Shinebed Global E-commerce Co., Ltd., founders of Bedsure. Blending on-trend styles, affordability, and the right amount of luxury, Double Stitch serves as the bedding option for the consumer ready to invest in a quality sleep experience. Double Stitch is committed to using natural fabrics and motivated by comfort, tranquility, and enduring longevity. Double Stitch’s craftsmanship and attention to detail help customers evolve and transform their spaces into sanctuaries of relaxation. For more information, visit Double Stitch’s brand website, Amazon storefront, and Instagram (@doublestitchhome).

Media Inquiries:

Double Stitch Brand Team, hello@doublestitch.com 

PANAMA CITY, April 11, 2025 /PRNewswire/ — BingX, a global leading cryptocurrency exchange, is excited to announce the BABY token has been added to its Xpool feature. Starting April 7 at 10:00 (UTC) through April 14 at 10:00 (UTC), BingX users can stake USDT in Xpool to share a total reward pool of 50,000 BABY Points. Participants can redeem BABY Points at a 1:1 ratio for BABY tokens, providing early access to Babylon’s Bitcoin staking protocol without the need to lock actual BTC, ahead of BABY’s official spot listing and perpetual futures trading on April 10.

BABY is the governance and utility token of Babylon, a protocol that allows native Bitcoin staking without bridging or wrapping BTC. The token powers validator delegation, governance functions, and staking incentives. Its addition to X-Pool reflects BingX’s continued focus on providing access to promising early-stage projects through simple and flexible mechanisms.

By staking USDT in Xpool, BingX users gain a passive income opportunity tied to the growth of Bitcoin staking activity on Babylon. This is especially useful for those who want to participate in emerging staking models without the complexity of running nodes or interacting directly with smart contracts. Xpool ensures a streamlined process with no lock-up requirements and real-time reward tracking.

“Our users have been asking for more diverse and meaningful token options in Xpool. With BABY, we are offering them exposure to a unique staking protocol built specifically for Bitcoin holders”, said Vivien Lin, Chief Product Officer of BingX. “You don’t need to be a validator or bridge assets to benefit as you can just stake USDT through Xpool and start earning. It is simple, efficient, and designed with user control in mind.”

Adding BABY to Xpool strengthens BingX’s position as a flexible platform for low-barrier token engagement. The BABY Xpool campaign bridges trending DeFi utilities with a centralized, user-friendly experience to support novel protocols like Babylon while rewarding users who move early.

About BingX 

Founded in 2018, BingX is a leading crypto exchange, serving over 20 million users worldwide. BingX offers diversified products and services, including spot, derivatives, copy trading, and asset management – all designed for the evolving needs of users, from beginners to professionals. BingX is committed to providing a trustworthy platform that empowers users with innovative tools and features to elevate their trading proficiency. In 2024, BingX proudly became the official crypto exchange partner of Chelsea Football Club, marking an exciting debut in the world of sports.

For more information please visit: https://bingx.com/